November 28
Africa: Unitaid Invests U.S.$22m to Accelerate Access to Lenacapavir, a Groundbreaking New HIV Prevention Drug
Ahead of World AIDS Day, Unitaid is announcing a US$22 million investment to accelerate the introduction and access to lenacapavir, a revolutionary long-acting HIV prevention… Read more »
September 25
Africa: New Unitaid Report Calls for More Effective, Affordable Gonorrhea Diagnostics to Address Rising Infections and Antimicrobial Resistance
The report examines access gaps for tools that support sexual and reproductive health, calling for a concerted effort to address market gaps and incentivize the development and… Read more »
September 18
Africa: UNITAID Unveils New Report On Technologies to Prevent Cervical Cancer, a Leading Killer of Women Worldwide
Key points Read more »
August 21
Nigeria: First Nigerian Manufacturer Obtains Who Prequalification for Key Malaria Prevention Drug
Swiss Pharma Nigeria Limited (Swipha), with support from MMV and Unitaid, becomes the first Nigerian manufacturer of WHO-prequalified sulfadoxine-pyrimethamine, used for preventing… Read more »
July 15
Africa: New Unitaid Report - World's Leading HIV Drug Proven to Have Reduced Global CO2 Emissions By 26 Million Tons
The transition from efavirenz to dolutegravir (DTG) in HIV treatment is estimated to reduce total carbon emissions by 26 million tons of CO2 equivalent by 2027 thanks to the shift… Read more »
May 06
Africa: Industry Engagement Forum in Lagos Aims to Increase Health Product Manufacturing in Africa
The 2024 Industry Engagement Forum, themed "Unlocking Healthcare Value Chains and Driving Investment through Partnerships: Accelerating Equitable Access to Quality-Assured… Read more »
March 18
East Africa: Japan Commits U.S.$7.3 Million to Unitaid to Strengthen Access to Lifesaving Medical Oxygen in Kenya and Tanzania
Key points Read more »
UNITAID (Geneva)
Website: http://www.unitaid.eu/index.php
